Severe Multiorgan Failure Following Yellow Fever Vaccination
- PMID: 32466490
- PMCID: PMC7349955
- DOI: 10.3390/vaccines8020249
Severe Multiorgan Failure Following Yellow Fever Vaccination
Abstract
Background: The yellow fever (YF) vaccination is recommended by the WHO for people traveling or living in endemic areas at risk for yellow fever infections in Africa and South America. Although the live attenuated yellow fever vaccine is a safe and efficient vaccine, rare serious adverse events after vaccination have been reported.
Case presentation: We present the case of a 74-year-old male with multiorgan failure after yellow fever vaccination for a trip to Brazil. The patient required admission to the intensive care unit with a prolonged stay due to severe organ dysfunction. Five days after the YF vaccination, the patient experienced nausea, vomiting, diarrhea, and general illness. Three days later he sought medical attention and was transferred to the University Hospital Heidelberg with beginning multiorgan failure and severe septic shock, including hypotonia, tachypnea, thrombopenia, and acute renal failure the same day. Within one week after vaccination, antibodies against YF virus were already detectable and progressively increased over the next two weeks. Viral RNA was detected in serum on the day of admission, with a viral load of 1.0 × 105 copies/mL. The YF virus (YFV) RNA was also present in tracheal secretions for several weeks and could be detected in urine samples up to 20 weeks after vaccination, with a peak viral load of 1.3 × 106 copies/mL. After 20 weeks in the ICU with nine weeks of mechanical ventilation, the patient was transferred to another hospital for further recovery.
Conclusions: The risk for severe adverse events due to the YF vaccination should be balanced against the risk of acquiring a severe YF infection, especially in elderly travelers.
Keywords: multiorgan failure; vaccination; viscerotropic disease; yellow fever virus.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27. MMWR Recomm Rep. 2010. PMID: 20671663
-
Review of the risks and benefits of yellow fever vaccination including some new analyses.Expert Rev Vaccines. 2012 Apr;11(4):427-48. doi: 10.1586/erv.12.6. Expert Rev Vaccines. 2012. PMID: 22551029 Review.
-
Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period.J Travel Med. 2016 Mar 28;23(3):taw012. doi: 10.1093/jtm/taw012. Print 2016 Mar. J Travel Med. 2016. PMID: 27021495
-
Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.Front Immunol. 2018 Aug 2;9:1756. doi: 10.3389/fimmu.2018.01756. eCollection 2018. Front Immunol. 2018. PMID: 30116244 Free PMC article.
-
Yellow fever disease in a renal transplant recipient: Case report and literature review.Transpl Infect Dis. 2019 Oct;21(5):e13151. doi: 10.1111/tid.13151. Epub 2019 Aug 13. Transpl Infect Dis. 2019. PMID: 31344763 Review.
Cited by
-
A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine.Vaccines (Basel). 2020 Jul 9;8(3):368. doi: 10.3390/vaccines8030368. Vaccines (Basel). 2020. PMID: 32660106 Free PMC article.
-
Current Flavivirus Research Important for Vaccine Development.Vaccines (Basel). 2020 Aug 27;8(3):477. doi: 10.3390/vaccines8030477. Vaccines (Basel). 2020. PMID: 32867038 Free PMC article.
References
-
- Reinhardt B., Jaspert R., Niedrig M., Kostner C., L’Age-Stehr J. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection. J. Med. Virol. 1998;56:159–167. doi: 10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources